Anti-Fibrotic Effects Of Nintedanib (bibf 1120) In Primary Human Lung Fibroblasts Derived From Patients With Idiopathic Pulmonary Fibrosis And From Non-Fibrotic Controls

被引:0
|
作者
Hostettler, K. E. [1 ]
Papakonstantinou, E. [2 ]
Klagas, J. [2 ]
Karakiulakis, G. [2 ]
Zhong, J. [1 ]
Tamm, M. [1 ]
Lardinois, D. [1 ]
Roth, M. [1 ]
机构
[1] Univ Basel Hosp, Basel, Switzerland
[2] Univ Thessaloniki, Thessaloniki, Greece
关键词
D O I
暂无
中图分类号
R4 [临床医学];
学科分类号
1002 ; 100602 ;
摘要
A3374
引用
收藏
页数:1
相关论文
共 50 条
  • [1] Anti-fibrotic effects of nintedanib (BIBF 1120) in primary human lung fibroblasts derived from idiopathic pulmonary fibrosis
    Hostettler, Katrin
    Papakonstantinou, Eleni
    Klagas, Ioannis
    Karakiulakis, George
    Tamm, Michael
    Lardinois, Didier
    Roth, Michael
    EUROPEAN RESPIRATORY JOURNAL, 2012, 40
  • [2] Anti-fibrotic effects of nintedanib in lung fibroblasts derived from patients with idiopathic pulmonary fibrosis
    Hostettler, Katrin E.
    Zhong, Jun
    Papakonstantinou, Eleni
    Karakiulakis, George
    Tamm, Michael
    Seidel, Petra
    Sun, Qingzhu
    Mandal, Jyotshna
    Lardinois, Didier
    Lambers, Christopher
    Roth, Michael
    RESPIRATORY RESEARCH, 2014, 15
  • [3] Anti-fibrotic effects of nintedanib in lung fibroblasts derived from patients with idiopathic pulmonary fibrosis
    Katrin E Hostettler
    Jun Zhong
    Eleni Papakonstantinou
    George Karakiulakis
    Michael Tamm
    Petra Seidel
    Qingzhu Sun
    Jyotshna Mandal
    Didier Lardinois
    Christopher Lambers
    Michael Roth
    Respiratory Research, 15
  • [4] Anti-fibrotic effects of pirfenidone in lung fibroblasts derived from patients with idiopathic pulmonary fibrosis
    Hostettler, Katrin
    Papakonstantinou, Eleni
    Klagas, Ioannis
    Bonovolias, Ioannis
    Sun, Qingzhu
    Tamm, Michael
    Lambers, Christopher
    Roth, Michael
    EUROPEAN RESPIRATORY JOURNAL, 2015, 46
  • [5] Nintedanib (BIBF 1120) prevents TGF-β-induced pro-fibrotic effects in primary human lung myofibroblasts derived from patients with idiopathic pulmonary fibrosis
    Hostettler, Katrin
    Papakonstantinou, Eleni
    Zhong, Jun
    Karakiulakis, George
    Lardinois, Didier
    Tamm, Michael
    Roth, Michael
    EUROPEAN RESPIRATORY JOURNAL, 2014, 44
  • [6] Anti-Fibrotic Effects of Azithromycin in Human Lung Fibroblasts from Idiopathic Pulmonary Fibrosis Patients Compared to Control Fibroblasts
    Funke, M.
    Krempaska, K.
    Schliep, R.
    Knudsen, L.
    Geiser, T. K.
    AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 2018, 197
  • [7] Anti-Fibrotic Effects Of Nintedanib On Lung Fibroblasts
    Rangarajan, S.
    Kurundkar, A.
    Kurundkar, D.
    Bernard, K.
    Sanders, Y.
    Ding, Q.
    Zhang, J.
    Zmijewski, J.
    Thannickal, V. J.
    AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 2015, 191
  • [8] Tolerability and efficacy of switching anti-fibrotic treatment from nintedanib to pirfenidone for idiopathic pulmonary fibrosis
    Sugino, Keishi
    Ono, Hirotaka
    Saito, Mikako
    Ando, Masahiro
    Tsuboi, Eiyasu
    PLOS ONE, 2024, 19 (06):
  • [9] Adipose-Derived Mesenchymal Stem Cells (ADSCs) Have Anti-Fibrotic Effects on Lung Fibroblasts from Idiopathic Pulmonary Fibrosis (IPF) Patients
    Ouji-Sageshima, Noriko
    Hiyama, Aiko
    Kumamoto, Makiko
    Kitabatake, Masahiro
    Hara, Atsushi
    Furukawa, Ryutaro
    Hontsu, Shigeto
    Kawaguchi, Takeshi
    Sawabata, Noriyoshi
    Muro, Shigeo
    Ito, Toshihiro
    CELLS, 2024, 13 (24)
  • [10] Non-Canonical Autophagy And The Anti-Fibrotic Effects Of Bibf-1120 In Ipf
    Rangarajan, S.
    Kurundkar, A.
    Zhang, J.
    Thannickal, V. J.
    AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 2014, 189